News - Page 150 - Psychedelic Alpha

Our 🎯 Q1 2026 Psychedelic Pipeline Bullseye Charts are now available.

Read more about the article Lobe Announces Krysalis VX Innovations Inc., a Company Equally Owned by Lobe Sciences Ltd. and Virtual Psychedelics Incorporated, Appointment of Interdisciplinary Team of Advisors

Lobe Announces Krysalis VX Innovations Inc., a Company Equally Owned by Lobe Sciences Ltd. and Virtual Psychedelics Incorporated, Appointment of Interdisciplinary Team of Advisors

Post published:October 6, 2021
Post category:Press Release

Read more about the article Psygen Announces use of Psilocybin in Human Trial and Provides Update on IP Portfolio

Psygen Announces use of Psilocybin in Human Trial and Provides Update on IP Portfolio

Post published:October 6, 2021
Post category:Press Release

Read more about the article Mydecine To Supply Lead Drug Candidate, MYCO-001, for Multi-Site NIDA Grant-Funded Smoking Cessation Study Lead by Dr. Matthew Johnson

Mydecine To Supply Lead Drug Candidate, MYCO-001, for Multi-Site NIDA Grant-Funded Smoking Cessation Study Lead by Dr. Matthew Johnson

Post published:October 5, 2021
Post category:Press Release

Read more about the article MindMed Announces Strategic Research Collaboration with Sphere Health

MindMed Announces Strategic Research Collaboration with Sphere Health

Post published:October 5, 2021
Post category:Press Release

Read more about the article Lobe Sciences and the World Boxing Association Announce Initiative Targeting mTBI and PTSD

Lobe Sciences and the World Boxing Association Announce Initiative Targeting mTBI and PTSD

Post published:October 4, 2021
Post category:Press Release

Read more about the article Psychedelic Bulletin: Delix Raises $70m Series A; Toronto Gets Psychedelics Research Centre; Elon Musk Endorses Psychedelics

Psychedelic Bulletin: Delix Raises $70m Series A; Toronto Gets Psychedelics Research Centre; Elon Musk Endorses Psychedelics

Post published:October 1, 2021
Post category:Psychedelic Bulletin

Read more about the article Mydecine Completes Spin-Out of U.S. Cannabis Assets

Mydecine Completes Spin-Out of U.S. Cannabis Assets

Post published:October 1, 2021
Post category:Press Release

Read more about the article MindMed Announces Appointment of Andreas Krebs and Carol Vallone as Directors and Transition of Bruce Linton

MindMed Announces Appointment of Andreas Krebs and Carol Vallone as Directors and Transition of Bruce Linton

Post published:September 30, 2021
Post category:Press Release

Read more about the article MINDCURE Announces Commencement of Trading on the OTCQX Best Market

MINDCURE Announces Commencement of Trading on the OTCQX Best Market

Post published:September 30, 2021
Post category:Press Release

Read more about the article PharmaTher Retains Former FDA Psychiatry Division Director Dr. Thomas Laughren as Regulatory Affairs Advisor

PharmaTher Retains Former FDA Psychiatry Division Director Dr. Thomas Laughren as Regulatory Affairs Advisor

Post published:September 29, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond. Psy Alpha Ltd is a company registered in England and Wales (16989109).

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.